€15 Million Global Trial to Test Phage Therapy as Antibiotic Alternative for Recurrent UTIs

€15 Million Global Trial to Test Phage Therapy as Antibiotic Alternative for Recurrent UTIs

A €15 million global trial is being conducted to test phage therapy as an alternative to antibiotics for recurrent urinary tract infections (UTIs). The trial aims to evaluate the safety and efficacy of phage therapy in treating UTIs. The trial is being conducted by a team of researchers from several countries, including India. The researchers are using a combination of phage therapy and conventional antibiotics to treat patients with recurrent UTIs. The trial is expected to provide valuable insights into the use of phage therapy in treating UTIs and may lead to the development of new treatments for this condition.